Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
BCYC BICYCLE THERAPEUTICS plc
- Stocks
- Healthcare
- NASDAQ: BCYC
Price (delayed)
$8.1
Market cap
$560.96M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$3.14
Enterprise value
-$229.41M
Bicycle Therapeutics is a clinical-stage biopharmaceutical company developing a novel class of medicines, referred to as Bicycles, for diseases that are underserved by existing therapeutics. Bicycles are fully synthetic short
Highlights
BCYC's debt has dropped by 93% year-on-year and by 35% since the previous quarter
BICYCLE THERAPEUTICS's quick ratio has increased by 45% YoY and by 7% QoQ
BCYC's equity has surged by 108% year-on-year but it is down by 7% since the previous quarter
BICYCLE THERAPEUTICS's EPS has increased by 29% YoY but it has decreased by 8% from the previous quarter
BICYCLE THERAPEUTICS's gross profit has decreased by 38% YoY and by 27% QoQ
BCYC's revenue is down by 38% YoY and by 27% QoQ
Key stats
What are the main financial stats of BCYC
Market
Valuations
Earnings
Shares outstanding
69.25M
Market cap
$560.96M
Enterprise value
-$229.41M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.76
Price to sales (P/S)
21.79
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-8.92
Revenue
$25.72M
Gross profit
$25.72M
Operating income
-$248.36M
Net income
-$203.22M
EBIT
-$207.76M
EBITDA
-$200.61M
Free cash flow
-$182.05M
Per share
Balance sheet
Liquidity
EPS
-$3.14
EPS diluted
-$3.14
Free cash flow per share
-$2.63
Book value per share
$10.7
Revenue per share
$0.37
TBVPS
$12.77
Total assets
$883.89M
Total liabilities
$143.56M
Debt
$2.61M
Equity
$740.33M
Working capital
$798.46M
Debt to equity
0
Current ratio
14.86
Quick ratio
14.57
Net debt/EBITDA
3.94
Margins
Efficiency
Dividend
EBITDA margin
-779.9%
Gross margin
100%
Net margin
-790.1%
Operating margin
-965.6%
Return on assets
-20.9%
Return on equity
-25.1%
Return on invested capital
-491.6%
Return on capital employed
-25.1%
Return on sales
-807.7%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
BCYC stock price
How has the BICYCLE THERAPEUTICS stock price performed over time
Intraday
-0.25%
1 week
-2.88%
1 month
8.14%
1 year
-63.48%
YTD
-42.14%
QTD
-4.59%
Financial performance
How have BICYCLE THERAPEUTICS's revenue and profit performed over time
Revenue
$25.72M
Gross profit
$25.72M
Operating income
-$248.36M
Net income
-$203.22M
Gross margin
100%
Net margin
-790.1%
The operating margin has plunged by 123% YoY and by 62% from the previous quarter
BCYC's net margin has dropped by 96% year-on-year and by 65% since the previous quarter
BICYCLE THERAPEUTICS's gross profit has decreased by 38% YoY and by 27% QoQ
The operating income has declined by 38% year-on-year and by 18% since the previous quarter
Price vs fundamentals
How does BCYC's price correlate with its fundamentals
Growth
What is BICYCLE THERAPEUTICS's growth rate over time
Valuation
What is BICYCLE THERAPEUTICS stock price valuation
P/E
N/A
P/B
0.76
P/S
21.79
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
-8.92
BICYCLE THERAPEUTICS's EPS has increased by 29% YoY but it has decreased by 8% from the previous quarter
BCYC's equity has surged by 108% year-on-year but it is down by 7% since the previous quarter
The stock's P/B is 75% below its 5-year quarterly average of 3.1 and 37% below its last 4 quarters average of 1.2
The P/S is 54% less than the 5-year quarterly average of 47.2 and 24% less than the last 4 quarters average of 28.7
BCYC's revenue is down by 38% YoY and by 27% QoQ
Efficiency
How efficient is BICYCLE THERAPEUTICS business performance
BICYCLE THERAPEUTICS's ROS has plunged by 106% YoY and by 66% from the previous quarter
The company's return on invested capital has shrunk by 81% YoY and by 52% QoQ
The ROE has grown by 49% YoY but it has contracted by 6% from the previous quarter
The ROA has grown by 31% YoY but it has contracted by 10% from the previous quarter
Dividends
What is BCYC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for BCYC.
Financial health
How did BICYCLE THERAPEUTICS financials performed over time
BICYCLE THERAPEUTICS's total assets has soared by 62% YoY but it has decreased by 8% from the previous quarter
BICYCLE THERAPEUTICS's quick ratio has increased by 45% YoY and by 7% QoQ
BCYC's debt is 100% smaller than its equity
BCYC's equity has surged by 108% year-on-year but it is down by 7% since the previous quarter
BICYCLE THERAPEUTICS's debt to equity has plunged by 100% from the previous quarter and by 100% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.